Rocket


News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

IGENE BIOTECHNOLOGY INC (IGNE) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/01/2009 8-K Quarterly results
01/21/2009 8-K Form 8-K - Current report
02/07/2008 8-K Form 8-K -- Current report
01/22/2008 8-K Changes in Registrant.s Certifying Accountant
Docs: "SECURITIES AND EXCHANGE COMMISSION",
"Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549"
11/06/2007 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and ...
Docs: "SEPARATION AGREEMENT This Separation Agreement is made and entered into as of the 31st day of October, 2007 by and between Igene Biotechnology, Inc. and Tate & Lyle Fermentation Products Ltd. . RECITALS A. Tate & Lyle and Igene entered into a Joint Venture Agreement on March 19, 2003, as amended, to create Astaxanthin Partners Ltd. and certain ancillary agreements to carry out the purpose of Astaxanthin Partners Ltd. . B. Tate & Lyle and Igene are the sole shareholders of the Company, with Igene owning 6,000 Class B Shares of the Company and Tate & Lyle owning 6,000 Class A Shares of the Company . C. Tate & Lyle and Igene wish to terminate their relationship as joint owners of the Company as set forth herein. AGREEMENT NOW, THEREFORE, in consideration of the foregoing Recitals, and of the ..."
05/10/2007 8-K Changes in Registrant.s Certifying Accountant, Financial Statements and Exhibits
Docs: "SECTION 4 - MATTERS RELATED TO ACCOUNTANTS AND FINANCIAL STATEMENTS",
"OF AGREEMENT FROM ACCOUNTANTS"
03/31/2006 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders
Docs: "SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS",
"4 - MATERIAL MODIFICATION DEFINING RIGHTS OF SECURITY HOLDERS"
05/16/2005 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial State...
Docs: "99 TO 8-K FILING OF MAY 16 2005"
02/17/2005 8-K Changes in Registrant.s Certifying Accountant, Financial Statements and Exhibits
Docs: "to Rule 13e-4(c)under the Exchange Act",
"16 - LETTER OF AGREEMENT"
10/01/2003 8-K Other events
Docs: "Item 5. Other Events"
05/13/2003 8-K Acquisition or disposition of assets, Financial statements and exhibits
Docs: "JOINT VENTURE AGREEMENT BETWEEN TATE & LYLE FERMENTATION PRODUCTS LTD. AND IGENE BIOTECHNOLOGY, INC."
02/20/2003 8-K Acquisition or disposition of assets, Financial statements and exhibits
Docs: "SECURITIES AND EXCHANGE COMMISSION",
"PURCHASE AND SEVERANCE AGREEMENT",
"Igene Sells ProBio Nutraceuticals"
01/04/2002 8-K Acquisition or disposition of assets, Financial statements and exhibits
Docs: "SECURITIES AND EXCHANGE COMMISSION",
"IGENE PURCHASES THEIR EXCLUSIVE SALES AGENT PROBIO",
"EXHIBIT 2 STOCK PURCHASE AGREEMENT AGREEMENT"
06/12/2001 8-K Changes in control of registrant
05/04/2001 8-K Changes in control of registrant

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy